Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122662) titled 'Efficacy and Safety of Tofacitinib in the Treatment of Genital Lichen Sclerosus: A Prospective Study' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shandong Academy of Medical Sciences
Condition:
Genital Lichen Sclerosus
Intervention:
Intervention group:Tofacitinib
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Intervention group:30;Control group:30;
Countrie...